Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer
- 31 May 2004
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 89-90, 533-537
- https://doi.org/10.1016/j.jsbmb.2004.03.063
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 16 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Diet: Dairy Products, Calcium, and Vitamin D and Risk of Prostate CancerEpidemiologic Reviews, 2001
- Redefining vitamin D insufficiencyThe Lancet, 1998
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model systemUrology, 1997
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI Journal of the National Cancer Institute, 1997
- Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the SkinJAMA, 1996
- Epidemiology of prostate cancer: molecular and environmental cluesUrology, 1996
- Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)Cancer Causes & Control, 1995
- A Prospective Study of Dietary Fat and Risk of Prostate CancerJNCI Journal of the National Cancer Institute, 1993